Cristal Therapeutics Starts Clinical Phase I Trial with Nanomedicine CriPec® Docetaxel in Patients with Solid Tumours
Cristal Therapeutics, a privately-held life sciences company developing innovative drugs against cancer and other diseases, announced the…
Recent Comments